siRNA for inhibiting c-Met expression and an anti-cancer composition comprising the same

Details for Australian Patent Application No. 2010339082 (hide)

Owner SAMYANG BIOPHARMACEUTICALS CORPORATION

Inventors Kim, Sun-Ok; Kim, Sang-Hee; Cho, Eun-Ah; In, Chang-Hoon

Agent Griffith Hack

Pub. Number AU-A-2010339082

PCT Pub. Number WO2011/081415

Priority 10-2009-0135665 31.12.09 KR

Filing date 28 December 2010

Wipo publication date 7 July 2011

International Classifications

A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 35/00 Antineoplastic agents

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/081415 Priority application(s): WO2011/081415

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010339143-Wind turbine

2010339080-Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same